Case Study: Oncology Wounds

Case Study Overview

Patient history

49 year old female with history of malignant disease, presented with T cell Lymphoma to left arm and satellite wound.  Wound had been present for 6 months, with silver dressings and enzyme alginogel used unsuccessfully.

Initial assessment

T cell lymphoma measured 5m in length x 4.5cm in width. The satellite wound measured 3.5cm in length x 3.5cm in width.

High levels of exudate were present, which meant that dressing changes were required 2-3 times per day.

Periwound skin was excoriated due to high exudate levels, and patient reported it was very itchy.

Wounds were malodorous, which patient found embarrassing, particular whilst at work in an office environment.

Patient reported a pain score of 8-10 on visual analogue scale (VAS).

Method

MaxioCel treatment commenced for evaluation period of 4 weeks, with multiple aims to protect granulation tissue, promote autolytic debridement, promote healing and to manage exudate and associated odour.

Results

At 2nd assessment, only 7 days after commencement of use of MaxioCel, dressing changes had reduced from 2-3 times per day to daily. Both exudate and odour reducing. Necrotic area and been removed and slough was softer and debriding well. Patient reported that periwound skin was less painful and itchy, and their pain score reduced from 8-10 to 2-5 on VAS.

Within 14 days, patient reported no pain, and wound was bridging with granulation tissue.

By conclusion of the evaluation (28 days) wound was successfully debrided. Patients pain had reduced to 1-3 on VAS, and no odour was present.

Patient and husband requested to extend evaluation, as they saw improvement with MaxioCel. By week 10, wound was granulating, and treatment could be discontinued.

 

Photos of T-Cell Lymphoma and Satellite Wound Before and After treatment with MaxioCel

Conclusion

The ease of use of MaxioCel, including  one-piece removal, allowed supported self care at home, as patients husband was confident in changing dressings. Patient commented:

“Since using the MaxioCel dressings I have seen a significant improvement in my affected tissue. The MaxioCel are so easy to take off, they don’t stick to the skin / wound like previous dressings also since using I noticed they don’t have a funny smell like others previously when had discharge from wound.”

 

To find out more about how MaxioCel can help your patients with oncology wounds, get in touch with us here

 

Since using the MaxioCel dressings I have seen a significant improvement in my affected tissue. The MaxioCel are so easy to take off, they don’t stick to the skin / wound like previous dressings.

Patient Feedback

References

A ten patient case study series of the impact of a 100% Chitosan based dressing with Bioactive Microfibre Gelling (BMG™) technology in individuals with oncology wounds, Susy Pramod, Wounds UK 2022